Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 721, pseudogene (RNU6-721P)
- Target
- RNU6-721P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA) family member (ancestral classification, not a functional member), Non-coding RNA, Other
01
Overview
RNU6-721P (RNA, U6 small nuclear 721, pseudogene) is a non-functional, processed pseudogene derived from U6 small nuclear RNA. U6 snRNA is a highly conserved component of the spliceosome, which plays a critical role in nuclear RNA splicing in eukaryotes by excising introns from pre-mRNA. The U6 pseudogenes, including RNU6-721P, are prevalent throughout the human genome, having arisen through retrotransposition predominantly mediated by L1 (LINE-1) retrotransposons. These pseudogenes do not encode functional RNA or proteins and do not participate in splicing or other cellular processes; their biological significance lies primarily in marking retrotranspositional activity and contributing to genomic architecture. RNU6-721P is not considered a therapeutic target and has no established roles in disease, pharmacology, or clinical biomarkers.
- Other names
- RNU6-721PRNA, U6 small nuclear 721, pseudogene
02
Biological functions
Other (no direct biological function; pseudogene counterparts of snRNAs do not contribute to cellular processes; functional U6 snRNA is involved in RNA splicing, but not pseudogenes)
03
Disease associations
Other (no established role; pseudogenes are typically non-functional, but may occasionally serve as markers of genome dynamics or retrotransposition activity)
04
Biomarkers
Other (may serve as a marker in genomic studies of retrotransposition dynamics or LINE activity in the genome, but not as a clinical biomarker)
Beyond the preview
Go deeper on RNA, U6 small nuclear 721, pseudogene (RNU6-721P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 721, pseudogene (RNU6-721P).